89bio (ETNB) News Today

89bio, Inc. (NASDAQ:ETNB - Get Free Report) saw a large increase in short interest in August. As of August 15th, there was short interest totalling 6,840,000 shares, an increase of 5.2% from the July 31st total of 6,500,000 shares. Based on an average trading volume of 954,000 shares, the days-to-cover ratio is currently 7.2 days.

89bio, Inc. (NASDAQ:ETNB - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation

89bio, Inc. (NASDAQ:ETNB - Get Free Report) saw a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 6,500,000 shares, a growth of 5.5% from the July 15th total of 6,160,000 shares. Based on an average trading volume of 985,100 shares, the short-interest ratio is presently 6.6 days.

89bio, Inc. (NASDAQ:ETNB - Free Report) - Stock analysts at Cantor Fitzgerald lifted their FY2024 earnings per share estimates for shares of 89bio in a research report issued to clients and investors on Wednesday, August 7th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will

89bio, Inc. (NASDAQ:ETNB - Free Report) - Equities researchers at Leerink Partnrs increased their Q3 2024 earnings estimates for 89bio in a research report issued on Tuesday, August 6th. Leerink Partnrs analyst T. Smith now expects that the company will earn ($0.53) per share for the quarter, up

Vanguard Group Inc. increased its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 9.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,722,971 shares of the company's stock after acquiring an additional 415,386

Raymond James increased their price target on 89bio from $50.00 to $53.00 and gave the company a "strong-buy" rating in a research note on Tuesday.

89bio (NASDAQ:ETNB) Stock Price Down 5% After Analyst Downgrade

Royal Bank of Canada cut their target price on 89bio from $13.00 to $12.00 and set a "sector perform" rating on the stock in a research note on Tuesday.

HC Wainwright reissued a "buy" rating and set a $29.00 target price on shares of 89bio in a report on Tuesday.

89bio (NASDAQ:ETNB - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.48) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.08. During the same quarter last year, the company earned ($0.52) earnings per share.

Shares of 89bio, Inc. (NASDAQ:ETNB - Get Free Report) have earned an average rating of "Moderate Buy" from the seven research firms that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the compan

Janus Henderson Group PLC grew its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 41.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,603,382 shares of the company's stock after purchasing an additional 3,688,241 shares durin

89bio (NASDAQ:ETNB) Stock Price Up 7.6%

89bio (NASDAQ:ETNB) Shares Down 3.4%

Westfield Capital Management Co. LP boosted its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 22.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,164,147 shares of the company's stock after purchasing an addit

89bio (NASDAQ:ETNB) Trading 9% Higher

89bio, Inc. (NASDAQ:ETNB - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The

Capstone Investment Advisors LLC bought a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The firm bought 103,767 shares of the company's stock, valued at approximately $1,208,000. Capstone Investment Advisors LLC own

89bio (NASDAQ:ETNB) Trading Down 3.9%

Cantor Fitzgerald reissued an "overweight" rating and issued a $29.00 target price on shares of 89bio in a research report on Monday.

Wellington Management Group LLP purchased a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 239,027 shares of the company's stock, valued at approxim

89bio (NASDAQ:ETNB) Shares Up 7.4%

Orchard Capital Management LLC boosted its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 36.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 739,208 shares of the compan

89bio (NASDAQ:ETNB) Shares Down 9.1%

Parkman Healthcare Partners LLC lowered its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 39.6% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 219,448 shares of the company's stock after selling 144,105 shares during the period. Parkman Healthca

89bio (NASDAQ:ETNB) Trading 8.8% Higher

Cantor Fitzgerald reissued an "overweight" rating and set a $29.00 price objective on shares of 89bio in a report on Wednesday.

Superstring Capital Management LP bought a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,021,477 shares of the company's stock, valued at approximately $11,410

RTW Investments LP acquired a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,578,931 shares of the company's stock, valued at approximately $62,317,000. 89bi

89bio (NASDAQ:ETNB) Trading Up 8.3%

89bio, Inc. (NASDAQ:ETNB - Get Free Report) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 10,120,000 shares, a decline of 5.9% from the April 30th total of 10,750,000 shares. Based on an average daily volume of 1,050,000 shares, the short-interest ratio is presently 9.6 days.

Monashee Investment Management LLC purchased a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 140,000 shares of the comp

Westfield Capital Management Co. LP raised its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 34.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,761,148 shares of the company's stock after purchasing an additional 449,262 shares during the p